Analysts' Upgrades, Downgrades: RIM

Change in Ratings

Research in Motion ( RIMM) added to Goldman's conviction buy list based on valuation, a stronger dollar and attractive pipeline. Sees 44% upside to its 12-month target of $68, based on 19x P/E.

J.M. Smucker ( SJM) upgraded at Merrill from Underperform to Buy. $48 price target. Estimates also raised to reflect stronger expected volume and lower commodity costs.

Sunoco ( SUN) downgraded at Deutsche Bank from Hold to Sell. Valuation call, based on lower expected demand and oil prices.

United Therapeutics ( UTHR) upgraded at Piper Jaffray to Neutral from Sell. Says near-term risk is limited following sell-off. Lowered target price to $60 from $71.

Stock Comments/EPS Changes

Medtronic ( MDT) target cut at Credit Suisse to $37 from $49 based on low visibility following Q2 results. Maintained Neutral rating.

St. Jude Medical ( STJ) target lowered at Credit Suisse to $31 from $38. Says 2009 is likely to be very challenging and foreign exchange is a big headwind. Maintained Neutral rating.

This article was written by a staff member of TheStreet.com.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says